Angiotensin Receptor Blockers for Hypertension
Links shared publicly online about this topic
Access : Aliskiren vs. Angiotensin Receptor Blockers in Hypertension: Meta-Analysis of Randomized Controlled Trials : American Journal of Hypertension
nature.com — “The American Journal of Hypertension, a peer reviewed journal, provides a forum for scientific inquiry of the highest standard in the fields of hypertension and related cardiovascular disease. AJH publishes articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology. Published weekly online and once a month in print.” View full resource at nature.com
Most Recently Shared on April 21, 2011 at 4:37 pm By:
Aliskiren is as effective as angiotensin receptor blockers in controlling blood pressure: http://bit.ly/h1EeGg
Angiotensin II Receptor Blocker (ARB) for Hypertension - MPR
empr.com — “A list of Angiotensin II Receptor Blocker (ARB) and combination of ARB and other hypertension medications used for hypertension (HTN).” View full resource at empr.com
Most Recently Shared on September 29, 2009 at 5:38 pm By:
MPR News: Angiotensin II Receptor Blocker (ARB) for Hypertension: A list of Angiotensin II Receptor Bl.. http://bit.ly/108Zly
Cardiology Medical News about Hypertension Angiotensin II Type 1 Receptor Blockers
mdlinx.com — “Angiotensin Receptor Blockers for Management of Hypertension” View full resource at mdlinx.com
Most Recently Shared on July 1, 2010 at 8:25 am By:
Angiotensin Receptor Blockers for Management of Hypertension: Southern Medical Journal http://bit.ly/a8iQrB #cardio #mdlinx
Family Med Medical News about Hypertension Angiotensin II Type 1 Receptor Blockers
mdlinx.com — “Angiotensin Receptor Blockers for Management of Hypertension” View full resource at mdlinx.com
Most Recently Shared on July 1, 2010 at 10:52 pm By:
Angiotensin Receptor Blockers for Management of Hypertension: Southern Medical Journal http://bit.ly/d7Pxeb #GM #mdlinx
Angiotensin receptor blockers associated with lower risk of Alzheimer's disease
sciencedaily.com — “Researchers have found that angiotensin receptor blockers -- a particular class of anti-hypertensive medicines -- are associated with a striking decrease in the occurrence and progression of dementia.” View full resource at sciencedaily.com
Most Recently Shared on January 14, 2010 at 3:07 pm By:
Angiotensin receptor blockers associated with lower risk of Alzheimer's disease Researchers have found that angiotens.. http://bit.ly/65Dy7R
Angiotensin receptor blockers associated with lower risk of Alzheimer's disease
feeds.sciencedaily.com — “Researchers have found that angiotensin receptor blockers -- a particular class of anti-hypertensive medicines -- are associated with a striking decrease in the occurrence and progression of dementia.” View full resource at feeds.sciencedaily.com
Most Recently Shared on January 14, 2010 at 3:13 pm By:
Angiotensin receptor blockers associated with lower risk of Alzheimer's disease: Researchers have found that angio... http://bit.ly/7M6X33
Meta-analysis: Angiotensin receptor blockers linked to modest increase in risk for new cancers | HemOncToday
hemonctoday.com — “The use of angiotensin receptor blockers, a widely used class of hypertension medications, has been linked to a modest increase in the risk for” View full resource at hemonctoday.com
Most Recently Shared on June 14, 2010 at 1:36 pm By:
Meta-analysis: #Angiotensin receptor blockers linked to modest increase in risk for new #cancers http://ht.ly/1Yaf1
Meta-analysis: Angiotensin receptor blockers linked to modest increase in risk for new cancers
endocrinetoday.com — “The use of angiotensin receptor blockers, a widely used class of hypertension medications, has been linked to a modest increase in the risk for” View full resource at endocrinetoday.com
Most Recently Shared on June 14, 2010 at 1:38 pm By:
Meta-analysis: #Angiotensin receptor blockers linked to modest increase in risk for new #cancers http://ow.ly/1YaiZ
Family Medicine News & Articles - MDLinx - Angiotensin II Type 1 Receptor Blockers Hypertension Vascular Diseases on #MDlinx
mdlinx.com — “Family Medicine News & Articles - MDLinx - Angiotensin II Type 1 Receptor Blockers Hypertension Vascular Diseases on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 11, 2010 at 1:06 am By:
Role of olmesartan in combination therapy in blood pressure control and vascular function: Vascular Hea... http://bit.ly/9Vg7QA #GM #mdlinx
Angiotensin II Receptor Blockers (ARB) - drug class, medical uses, medication side effects, and drug interactions by MedicineNet.com
medicinenet.com — “Angiotensin ii receptor blockers (arbs) are drugs used for controlling high blood pressure, treating heart failure and preventing kidney failure in people with diabetes or hypertension. read about uses, drug interactions and side effects.” View full resource at medicinenet.com
Most Recently Shared on January 20, 2010 at 12:38 am By:
MedicineNet: Angiotensin II Receptor Blockers (ARB) http://bit.ly/657a0e Full http://bit.ly/7uNmXE
Angiotensin II Receptor Blockers (ARB) - drug class, medical uses, medication side effects, and drug interactions by MedicineNet.com
medicinenet.com — “Angiotensin II receptor blockers (ARBs) are drugs used for controlling high blood pressure, treating heart failure and preventing kidney failure in people with diabetes or hypertension. Read about uses, drug interactions and side effects.” View full resource at medicinenet.com
Most Recently Shared on June 14, 2010 at 4:31 pm By:
Angiotensin receptor blockers (ARBs) are in the news. Learn more about this class of high blood pressure medication. http://bit.ly/aN3nkq
Effect of Combination Therapy with the Angiotensin Receptor Blocker Losartan plus Hydrochlorothiazide on Brain Perfusion in Patients with both Hypertension and Cerebral Hemodynamic Impairment due to Symptomatic Chronic Major Cerebral Artery Steno-Occlusiv
content.karger.com — “Effect of Combination Therapy with the Angiotensin Receptor Blocker Losartan plus Hydrochlorothiazide on Brain Perfusion in Patients with both Hypertension and Cerebral Hemodynamic Impairment due to Symptomatic Chronic Major Cerebral Artery Steno-Occlusive Disease: A SPECT Study” View full resource at content.karger.com
Most Recently Shared on March 13, 2012 at 9:53 pm By:
Effect of Combination Therapy with the Angiotensin Receptor Blocker Losartan plus Hydrochlorothiazide on Brain P... http://t.co/BWLZSPLM
ingentaconnect Is the angiotensin receptor blocker cancer risk overstated?
ingentaconnect.com — “ingentaconnect Is the angiotensin receptor blocker cancer risk overstated?” View full resource at ingentaconnect.com
Most Recently Shared on May 18, 2011 at 9:09 pm By:
Is the angiotensin receptor blocker cancer risk overstated?: (Source: Reactions) http://bit.ly/m9ydt5
Angiotensin Receptor Blockers and Cancer - UKidney.com
ukidney.com — “View Dr. Jordan Weinstein Profile at UKidney.com” View full resource at ukidney.com
Most Recently Shared on June 21, 2010 at 6:31 pm By:
KG likes UKidney's opinion on hot button ARB's and cancer.http://www.ukidney.com/nephrology-blog/angiotensin-receptor-blockers-and-cancer
A current evaluation of the safety of angiotensin receptor blockers an
dovepress.com — “Peer reviewed article authored by (Siragy HM). Read article or submit your manuscript for publishing.” View full resource at dovepress.com
Most Recently Shared on May 23, 2011 at 7:02 pm By:
A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors. http://bit.ly/iD98aC
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Yvo Sijpkens MD
Internist-Nephrologist, Expert in Hypertension and Chronic Kidney Disease, Focus on Cardiovascular and Renal Protection by Lifestyle, Vit D and Pharmacotherapy
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

